Application
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);Application
Figure 1: Western blot analysis using XRCC6 mAb against human XRCC6 (AA: 6-214) recombinant protein. (Expected MW is 49.7 kDa)Application
Figure 2: Western blot analysis using XRCC6 mAb against HEK293 (1) and XRCC6 (AA: 6-214)-hIgGFc transfected HEK293 (2) cell lysate.Application
Figure 3: Western blot analysis using XRCC6 mouse mAb against Hela (1), PC-2 (2), A549 (3), A431 (4), HepG2 (5), K562 (6) cell lysate.Application
Figure 4: Immunofluorescence analysis of MCF-7 cells using XRCC6 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin. Secondary antibody from Fisher (Cat#: 35503)Application
Figure 5: Flow cytometric analysis of A431 cells using XRCC6 mouse mAb (green) and negative control (red).Application
Figure 6: Immunohistochemical analysis of paraffin-embedded endometrial cancer tissues using XRCC6 mouse mAb with DAB staining.Application
Figure 7: Immunohistochemical analysis of paraffin-embedded cervical cancer tissues using XRCC6 mouse mAb with DAB staining.| Product Name | XRCC6 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | ML8; KU70; TLAA; CTC75; CTCBF; G22P1 |
| Immunogen | Purified recombinant fragment of human XRCC6 (AA: 6-214) expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBIHCICCFCMICC/IF |
| WB:1:250~1:1000 IHC:1:20~1:100 ICC:1:100~1:200 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | ML8 KU70 TLAA CTC75 CTCBF G22P1 |
|---|---|
| Molecular Weight(MW) | 69.8kDa |
| Entrez Gene | 2547 |
|---|
Application
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Application
Figure 1: Western blot analysis using XRCC6 mAb against human XRCC6 (AA: 6-214) recombinant protein. (Expected MW is 49.7 kDa)
Application
Figure 2: Western blot analysis using XRCC6 mAb against HEK293 (1) and XRCC6 (AA: 6-214)-hIgGFc transfected HEK293 (2) cell lysate.
Application
Figure 3: Western blot analysis using XRCC6 mouse mAb against Hela (1), PC-2 (2), A549 (3), A431 (4), HepG2 (5), K562 (6) cell lysate.
Application
Figure 4: Immunofluorescence analysis of MCF-7 cells using XRCC6 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin. Secondary antibody from Fisher (Cat#: 35503)
Application
Figure 5: Flow cytometric analysis of A431 cells using XRCC6 mouse mAb (green) and negative control (red).
Application
Figure 6: Immunohistochemical analysis of paraffin-embedded endometrial cancer tissues using XRCC6 mouse mAb with DAB staining.
Application
Figure 7: Immunohistochemical analysis of paraffin-embedded cervical cancer tissues using XRCC6 mouse mAb with DAB staining.| Application Notes | WB:1:250~1:1000 IHC:1:20~1:100 ICC:1:100~1:200 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Purified antibody in PBS with 0.05% sodium azide. |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
